Original article

DOI: 10.1016/j.gastre.2023.01.009

mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels)

Los inhibidores de mTOR como potencial factor predisponente para la hepatitis crónica E: resultados del estudio prospectivo colaborativo CHES (Chronic Hepatitis E Screening in patients with immune impairment and increased transaminases levels)

Descargar PDF

Mar Riveiro-Barcielaa,b,c, Luisa Roadea,c, Joan Martínez-Campreciosa,c, Judit Vidal-Gonzáleza,c, Basilio Rodríguez-Diezd, Manel Perellóe, Guillermo Ortíf, Virginia Robles-Alonsob,g, Cristina Berasteguih, Jordi Navarroi, Fernando Martínez-Vallej,c, Itxarone Bilbaob,k, Lluis Castellsa,b,c, Meritxell Ventura-Cotsa,b,c, Jordi Llanerasa,c, Ariadna Rando-Segural, Xavier Fornsb,m, Sabela Lensb,m, Martín Prietob,n, María García-Elizn..., Arkaitz Imazo, Francisco Rodríguez-Fríasb,p, Maria Butia,b,c,

Autor para correspondencia

mbuti@vhebron.net

Corresponding author.

, Rafael Estebana,cVer más

a Liver Unit, Internal Medicine Department, Hospital Universitario Vall d’Hebrón, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain

b Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain

c Universitat Autònoma de Barcelona, Department of Medicine, Barcelona, Spain

d Rheumatology Department, Hospital Universitario Vall d’Hebrón, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain

e Nephrology Department, Hospital Universitario Vall d’Hebrón, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain

f Department of Hematology, Hospital Universitario Vall d’Hebrón, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain

g Digestive System Research Unit, Hospital Universitario Vall d’Hebrón, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain

h Pneumology Department, Hospital Universitario Vall d’Hebrón, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain

i Infectious Diseases Department, Hospital Universitario Vall d’Hebrón, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain

j Systemic Autoimmune Diseases Unit, Internal Medicine Department, Hospital Universitario Vall d’Hebrón, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain

k Liver Transplant Unit, Hospital Universitario Vall d’Hebrón, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain

l Microbiology Department, Hospital Universitario Vall d’Hebrón, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain

m Hospital Clínic, Barcelona, IDIBAPS, Universidad de Barcelona, Spain

n Liver Transplantation and Hepatology Unit, La Fe Hospital, Valencia, Spain

o Infectious Diseases Department, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain

p Liver Pathology Unit, Departments of Biochemistry and Microbiology, Clinical Laboratories, Vall d’Hebron University Hospital, Spain

Ver más

Ver resumen